biotechnology Latest News

Antibody therapy is expected to be a major advance in the treatment of dogs with severe immunologic conditions.

One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types.

IGDRASOL will present updates on Cynviloq™, its late clinical stage paclitaxel nanoparticle formulation.

KIND-005 is expected to be a major new therapy for the treatment of laminitis in...

Grenoble, France, 18th March 2013, CYTOO, a life science systems & tools company providing disruptive solutions for cell-based assays and High Content Screening (HCS), is delighted to announce that Olivier Pasquier has joined the team as Chief...

The Online School will teach the learners Biotechnology, Bioscience, Biology, Biochemistry and integrate Social Sciences, Math, and hands-on practical laboratory experiments. Upon completion learners will be equipped for the scientific workforce.

Sorrento Therapeutics, Inc. ("STI"; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company focused on the development of oncologic agents for the treatment of cancers.

IGDRASOL today announced that the Company’s Chief Scientific Officer, Kouros Motamed, Ph.D., will present at the Breakthroughs in Basic & Translational Cancer Research Conference, February 25th, 2013, Maui, HI.

ABLE-AG the apex industry body for the agri-biotech sector in the country, expressed its disappointment over the continued delay in the approval process for Bt brinjal, India’s first biotech food crop.

KIND-002 is expected to be a major new therapy for severe cutaneous diseases in dogs.

A new report by visiongain predicts that the world market for vaccines will reach $48bn in 2015. From this market, vaccine contract manufacturing will reach $0.62bn in 2015.

CYTOO will attend the BPS Annual Meeting in Philadelphia to present its innovative Cell Culture Platform, based on adhesive micropatterns. After the launch of the CYTOOplates Motility, the company has the pleasure to sponsor the Motility subgroup.

HyTest was able to maintain its high growth in 2012 despite the global economic downturn. Growth over the previous year is 25% and turnover at the end of the fiscal year ending in October was 12.7 million Euros (17 million USD).

Highly Regarded Veterinary Marketing Executive to Join Kindred Bio’s Board

IGDRASOL today announced that the Company’s Chief Operating Officer, Larn Hwang, Ph.D., will present at the Tumor Invasion and Metastasis conference, January 21st , 2013, San Diego, CA.

KIND-001, a potent and specific inhibitor of inflammatory cytokines, is expected to be a major new therapy for diseases in dogs.

IGDRASOL today announced that Dr. Vuong Trieu, CEO of IGDRASOL, will discuss an overview of the company and the clinical development program for IG-001: a chemical polymer-bound nanoparticle paclitaxel entering phase III clinical testing.

Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™". The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012.

Personalization of paclitaxel therapy by combination of next generation nanoparticle paclitaxel and point-of-care therapeutic drug monitoring and biomarker testing.

The 6th Annual Holiday Food Drive sponsored by the Hepatitis B Foundation and Pennsylvania Biotechnology Center collects record amounts of food and cash donations for local food pantry.

The scientists who led the team that developed Glybera, the first gene therapy drug approved for use in the Western world, provide a fascinating first-person account of their pioneering work in Human Gene Therapy.

Antibody therapy is expected to be a major advance in the treatment of dogs with severe immunologic conditions.

MassBio to Host Life Sciences Open House in Marlborough, MA, After Recognizing the City as a Major Biotechnology Hub in the Commonwealth of Massachusetts

One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types.

IGDRASOL will present updates on Cynviloq™, its late clinical stage paclitaxel nanoparticle formulation.

KIND-005 is expected to be a major new therapy for the treatment of laminitis in...

Grenoble, France, 18th March 2013, CYTOO, a life science systems & tools company providing disruptive solutions for cell-based assays and High Content Screening (HCS), is delighted to announce that Olivier Pasquier has joined the team as Chief...

The Capital Area Biotechnology Partnership’s free Biotechnology Showcase is set for April 17th at Harrisburg University of Science and Technology in PA.

CYTOO, a life science systems & tools company providing disruptive solutions for cell-based assays and High Content Screening (HCS) is proud to announce that CYTOO’s adhesive micropatterns are mentioned in more than 30 publications, covering a wide...

The Online School will teach the learners Biotechnology, Bioscience, Biology, Biochemistry and integrate Social Sciences, Math, and hands-on practical laboratory experiments. Upon completion learners will be equipped for the scientific workforce.

Sorrento Therapeutics, Inc. ("STI"; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company focused on the development of oncologic agents for the treatment of cancers.

Regeneron Named GlobalData’s Innovative Mid-Cap Biotech Benchmark Leader due to Eylea Territory Expansions

PolyScience heated circulating water baths, available in 23 different models, can achieve temperatures as high as 200°C with temperature stabilities as exacting as ±0.005°C.

Dutch business intelligence publisher Patent 27℠ invites life sciences companies worldwide to participate in its pilot procedure. Patent 27 BV offers the first 250 participants a free bi-annual service contract.

IGDRASOL today announced that the Company’s Chief Scientific Officer, Kouros Motamed, Ph.D., will present at the Breakthroughs in Basic & Translational Cancer Research Conference, February 25th, 2013, Maui, HI.

Mary Ann Liebert, Inc., publishers is pleased to announce the appointment of Robert Lanza, MD as Editor-in-Chief of BioResearch Open Access effective immediately.

Bharatbook.com glad to promote a new report on "Animal Biotechnology - Technologies, Markets and Companies" which gives in-depth analysis on the Animal Biotechnology.

ABLE-AG the apex industry body for the agri-biotech sector in the country, expressed its disappointment over the continued delay in the approval process for Bt brinjal, India’s first biotech food crop.

On June 13th of 2013, diverse members of the Midwest BioScience Industry will be joining together in downtown Chicago around their common mission to improve the lives of patients suffering from catastrophic disease.

KIND-002 is expected to be a major new therapy for severe cutaneous diseases in dogs.

A new report by visiongain predicts that the world market for vaccines will reach $48bn in 2015. From this market, vaccine contract manufacturing will reach $0.62bn in 2015.

CYTOO will attend the BPS Annual Meeting in Philadelphia to present its innovative Cell Culture Platform, based on adhesive micropatterns. After the launch of the CYTOOplates Motility, the company has the pleasure to sponsor the Motility subgroup.

HyTest was able to maintain its high growth in 2012 despite the global economic downturn. Growth over the previous year is 25% and turnover at the end of the fiscal year ending in October was 12.7 million Euros (17 million USD).

Highly Regarded Veterinary Marketing Executive to Join Kindred Bio’s Board

IGDRASOL today announced that the Company’s Chief Operating Officer, Larn Hwang, Ph.D., will present at the Tumor Invasion and Metastasis conference, January 21st , 2013, San Diego, CA.

‘BioAsia’ 2013 - officials from biopharma regulatory agencies across the globe. Prominent confirmations are USA, South Africa, Sri lanka, Philippines, Czech Republic, Malaysia, Jordan, republic of Lithuania, Ghana, London, Sweden and India.

Pharma industry experts buzzing about Pharma Market Research Conference on Feb 5-6. The event is selling out fast, so people are registering while they still have a chance.

Korilog, an IT specialist that designs solutions facilitating the use of heterogeneous biological information systems, has developed KLAST, a sequence-comparison technology for DNA, RNA and proteins.

Immune Response BioPharma, Inc. Posts 2nd Half 2012 & Full Year Results

BioAsia,Asias biggest technology & bio-business platform for Biotechnology & Life sciences announced that Spain will be the Country Partner and GVK Biosciences will be the principal industry sponsor for the 10th edition of BioAsia – BioAsia 2013

‘Goose Tracker’ is designed to suit pharmaceutical industry’s urgent need to meet GS1 track and trace requirements, and ensure legislative compliance cost effectively

KIND-001, a potent and specific inhibitor of inflammatory cytokines, is expected to be a major new therapy for diseases in dogs.

IGDRASOL today announced that Dr. Vuong Trieu, CEO of IGDRASOL, will discuss an overview of the company and the clinical development program for IG-001: a chemical polymer-bound nanoparticle paclitaxel entering phase III clinical testing.

Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™". The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012.

Personalization of paclitaxel therapy by combination of next generation nanoparticle paclitaxel and point-of-care therapeutic drug monitoring and biomarker testing.

The 6th Annual Holiday Food Drive sponsored by the Hepatitis B Foundation and Pennsylvania Biotechnology Center collects record amounts of food and cash donations for local food pantry.

Close Out 2012 Right By Making Sure You Sign Up for the 2013 Pharma CI Europe Conference at Zurich Marriott Hotel in on February 19-20, 2013.

Before Saying Goodbye to 2012, Make Sure You Say Hello to the 2013 Pharma Market Research Conference at Hilton Woodcliff Lake Hotel in New Jersey on February 5-6, 2013.

CYTOO will offer a significant discount on all CYTOO Motility products at the ASCB 2012 Annual meeting in San Francisco: attendees are invited to visit ASCB Booth #329 for this exclusive offer!

CYTOO will launch the CYTOOplates Motility to study cell migration for screening applications in both oncology and drug discovery at the ASCB 2012 Annual meeting in San Francisco, USA.

A new CO2 sensor combines precise and reliable determination of dissolved CO2, with the performance benefits of Intelligent Sensor Management.

DLI ranked by the Phoenix Business Journal as the No1 Bioinformatics training & Biotechnology school in Hyderabad, India. This is now going to start a new batches in December 2012 .

The new location for the 2013 Pharma Market Research Conference is the Hilton Woodcliff Lake Hotel in Woodcliff Lake, New Jersey. Excitement is building for this event that's critical to the pharmaceutical, biotechnology, and medical device industry.

BioAsia, has opened the nomination process to all scientists & students pursuing research in the areas of biotechnology / life sciences or have made a significant contribution to the field of life sciences industry.

Two patents were issued covering a unique multi-well system to screen agents such as antibodies, and a novel method to screen single cells for the production of biologically active agents. Each should accelerate the discovery of new cures.

Distinguished Pharmaceutical Executive to Join Kindred Bio’s Board

Kalos has recently been accepted into the new Get Coached to Get Capital program offered by CONNECT, a San Diego-based innovation accelerator. The program seeks innovation and offers coaching to give a high-profile presentation to investors.

An event for buyers and suppliers in the pharmaceutical, biotechnology, and natural health products industries

engageIndia has partnered with the ultimate global forum on Lifesciences, BioAsia, India to connect, discuss, explore and drive a bio-future poised to be shaped by the next industry trends: Biologics and Biosimilars.

The Journal of Commercial Biotechnology seeks applications for two volunteer associate editors with a specialty in management.